Marines donate plasma in fight against COVID-19
Sarahi Wilson, a phlebotomist assigned to Naval Medical Center San Diego, Calif., draws blood from a volunteer, July 14, 2020. The medical center employs more than 6,000 active duty military personnel, civilians and contractors in Southern California. (Photo by Navy Petty Officer 2nd Class Erwin Jacob V. Miciano.)
Recommended Content:
Coronavirus | Convalescent Plasma Collection Program
The COVID-19 Convalescent Plasma Collection Program (CCP) is a Department of Defense effort to collect 10,000 units of convalescent plasma donated by members of the military community who have recovered from the disease. Convalescent plasma will be used to treat critically ill patients and to support the development of an effective treatment against the disease. Eligible donors should contact the Armed Services Blood Program at https://www.militaryblood.dod.mil/Donors/COVID-19andBloodDonation.aspx to find a complete list of available collection centers.
Marines assigned to Marine Corps Recruit Depot San Diego in California who have tested positive for COVID-19 donated plasma at Naval Medical Center San Diego.
In support of the development of an effective treatment, The Defense Department launched a campaign in late May to collect 10,000 units of plasma from patients who have recovered from COVID-19.
"The hope is that these Marines who have tested positive and recovered from COVID-19 will have developed antibodies," said Ellyn Alcantara, a clinical nurse assigned to the medical center's blood donor center. "These antibodies could lead to developments in a treatment for COVID-19."
All of the Marines volunteered to donate their plasma with the hope that their antibodies will help others.
A phlebotomist draws blood from Marine Corps Pfc. Johnny Cadengo at Naval Medical Center San Diego, July 14, 2020, to collect convalescent COVID-19 plasma. (Photo By: Navy Petty Officer 2nd Class Erwin Jacob V. Miciano.)
"It makes me feel good to be a part of the solution to this pandemic," said Marine Corps Pfc. Xavier Flores, a recent donor.
Upon arriving at the donor center, the Marines were given a medical health screening to determine their donor eligibility. Once they are cleared to donate plasma, a complete blood count and hematocrit test ensures the proportion of red blood cells in the body is optimal for donation and would have no adverse effects on the donor.
"A transfusion transmissible infection test will be performed on all donors as a part of their screening process," said Navy Lt. Therica Reynolds, the officer in charge of the medical center's Blood Donor Center. "We're trying to maximize our plasma collection and do our part for patient care."
Reynolds said apheresis — the plasma donation process — takes about an hour from the beginning of the screening process to the end of the collection. Convalescent COVID-19 plasma, or CCP, from recovered COVID-19-positive patients has been used at the medical center to help symptomatic patients recover.
"A qualified donor is eligible to donate every 28 days, and one person can potentially donate four doses, or bags, of CCP per visit," Reynolds said. "We highly encourage potential donors to make an appointment for one of our five apheresis machines. Anyone who has tested positive for COVID-19 and has recovered is encouraged to come into our [donation center] and get screened to donate."
NMCSD's mission is to prepare service members to deploy in support of operational forces, deliver high quality healthcare services and shape the future of military medicine through education, training and research. It employs more than 6,000 active duty military personnel, civilians and contractors.
Disclaimer: Re-published content may be edited for length and clarity. Read original post.
You also may be interested in...
Publication
1/5/2021
These messages are provided for you to use on your platforms with any of the images from the COVID-19 Toolkit.
Recommended Content:
Coronavirus
Publication
11/16/2020
This memorandum provides guidance to help protect individuals within the DoD community from coronavirus disease 2019 (COVID-19) for gatherings and activities during the November to January holiday season.
Recommended Content:
Coronavirus
Publication
10/21/2020
This guidance is an update to Defense Health Agency Return to Full Operations Concept of Operations, V5.0 (June 12, 2020) as it pertains to temperature checks in MTFs and DTFs. Based on recommendations from the Centers for Disease Control (CDC), previous guidance directed MTFs to take the temperature of all individuals entering the facility. Effective immediately, temperature checks are not required; however, screening of individuals entering MTFs and DTFs and healthcare personnel on duty in the MTF or DTF is to continue.
Recommended Content:
Coronavirus
Publication
8/6/2020
This memorandum supplements requirements in references (a), (b), and (c) with respect to coronavirus disease 2019 (COVID-19), and replaces reference (d). It provides pre- and posttravel guidance for purposes of force health protection (FHP) of Service members, DoD family members, DoD civilian employees, and DoD contractor personnel.
Recommended Content:
Coronavirus
Publication
6/24/2020
This message replaces guidance issued on March 31. It explains actions military pharmacies are taking to keep services and visits safe during the COVID-19 pandemic, and it outlines your pharmacy options as a TRICARE beneficiary.
Recommended Content:
Coronavirus | COVID Pharmacy Guidance | TRICARE Health Program
Publication
6/3/2020
TRICARE is announcing the continuation of the temporary exception to policy regarding the use of synchronous telehealth (TH) capabilities (both audio and video) for Applied Behavior Analysis (ABA) Family Adaptive Behavior Treatment Guidance services specifically during this COVID-19 pandemic.
Recommended Content:
Autism Care Demonstration | Coronavirus | TRICARE Health Program
Publication
5/26/2020
This memorandum provides force health protection (FHP) deployment and redeployment guidance for Service members (including Reserve Component (RC) and National Guard members in a title 10 or title 32 duty status) and DoD civilian employees deploying within and outside the United States during the COVID-19 pandemic, consistent with references (a) and (b).
Recommended Content:
Coronavirus
Publication
5/20/2020
This memorandum provides guidance for commanders to consider when making decisions to change health protection condition (HPCON) levels as COVID-19 pandemic conditions on and adjacent to our installations begin to improve.
Recommended Content:
Coronavirus
Publication
5/19/2020
This memorandum provides guidance on how each Military Medical Treatment Facility (MTF) and Dental Treatment Facility (DTF) may resume elective medical and dental procedures.
Recommended Content:
Public Health | Coronavirus
Publication
4/20/2020
All DoD Service members will stop movement, both internationally and domestically, while this memorandum is in effect. All DoD civilian personnel, and dependents of DoD Service members and DoD civilian personnel, whose travel is Government-funded will stop movement, both internationally and domestically, while this memorandum is in effect.
Recommended Content:
Coronavirus
Showing results 1 - 15
Page 1 of 2